• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric Patients.

作者信息

Zürbig Petra, Mischak Harald, Menne Jan, Haller Hermann

机构信息

mosaiques diagnostics GmbH, Hannover, Germany

mosaiques diagnostics GmbH, Hannover, Germany.

出版信息

Diabetes Care. 2019 Jan;42(1):e4-e5. doi: 10.2337/dc18-1322. Epub 2018 Nov 19.

DOI:10.2337/dc18-1322
PMID:30455331
Abstract
摘要

相似文献

1
CKD273 Enables Efficient Prediction of Diabetic Nephropathy in Nonalbuminuric Patients.CKD273能够有效预测非蛋白尿患者的糖尿病肾病。
Diabetes Care. 2019 Jan;42(1):e4-e5. doi: 10.2337/dc18-1322. Epub 2018 Nov 19.
2
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.PRIORITY 研究中高危个体的特征：尿蛋白质组学和醛固酮受体拮抗剂预防 2 型糖尿病肾病。
Diabet Med. 2018 Oct;35(10):1375-1382. doi: 10.1111/dme.13669. Epub 2018 Jun 6.
3
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.用于预测 2 型糖尿病合并微量白蛋白尿患者死亡率的尿蛋白质组学。
Cardiovasc Diabetol. 2018 Apr 6;17(1):50. doi: 10.1186/s12933-018-0697-9.
4
Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial.蛋白质组学预测与肾素-血管紧张素-醛固酮系统抑制预防2型糖尿病正常白蛋白尿患者早期糖尿病肾病（PRIORITY）：一项随机临床多中心试验的基本研究设计与原理
BMJ Open. 2016 Mar 2;6(3):e010310. doi: 10.1136/bmjopen-2015-010310.
5
The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients With Type 1 Diabetes.1 型糖尿病患者中非白蛋白尿性慢性肾脏病的存在及后果。
Diabetes Care. 2015 Nov;38(11):2128-33. doi: 10.2337/dc15-0641. Epub 2015 Aug 26.
6
Prevalent Rate of Nonalbuminuric Renal Insufficiency and Its Association with Cardiovascular Disease Event in Korean Type 2 Diabetes.韩国2型糖尿病患者中非白蛋白尿性肾功能不全的患病率及其与心血管疾病事件的关联
Endocrinol Metab (Seoul). 2016 Dec;31(4):577-585. doi: 10.3803/EnM.2016.31.4.577.
7
Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.非白蛋白尿性蛋白尿作为 2 型糖尿病肾病早期小管损伤的生物标志物。
Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.
8
Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.1型糖尿病中的糖尿病肾病：早期自然史、发病机制及诊断综述
Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2841. Epub 2016 Oct 4.
9
Nonalbuminuric Renal Insufficiency: Can It Be a Novel Category of Diabetic Nephropathy?非白蛋白尿性肾功能不全：它会是糖尿病肾病的一种新类型吗？
Endocrinol Metab (Seoul). 2016 Dec;31(4):533-534. doi: 10.3803/EnM.2016.31.4.533.
10
Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.CKD273肽分类器在预测慢性肾脏病进展中的效用。
Nephrol Dial Transplant. 2016 Feb;31(2):249-54. doi: 10.1093/ndt/gfv062. Epub 2015 Mar 19.

引用本文的文献

1
Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease.脂质组学揭示了糖尿病肾病进展中的潜在生物标志物和病理生理学见解。
Metabol Open. 2025 Mar 3;25:100354. doi: 10.1016/j.metop.2025.100354. eCollection 2025 Mar.
2
Assessment and Risk Prediction of Chronic Kidney Disease and Kidney Fibrosis Using Non-Invasive Biomarkers.利用非侵入性生物标志物评估和预测慢性肾脏病及肾脏纤维化。
Int J Mol Sci. 2024 Mar 26;25(7):3678. doi: 10.3390/ijms25073678.
3
A new era in the science and care of kidney diseases.
肾脏病科学与护理的新纪元。
Nat Rev Nephrol. 2024 Jul;20(7):460-472. doi: 10.1038/s41581-024-00828-y. Epub 2024 Apr 4.
4
Non-Invasive Biomarkers for Diagnosis, Risk Prediction, and Therapy Guidance of Glomerular Kidney Diseases: A Comprehensive Review.用于肾小球肾脏疾病的诊断、风险预测和治疗指导的非侵入性生物标志物：全面综述。
Int J Mol Sci. 2024 Mar 20;25(6):3519. doi: 10.3390/ijms25063519.
5
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.慢性肾脏病中尿肽和蛋白质组生物标志物的最新进展：系统评价。
Int J Mol Sci. 2023 May 23;24(11):9156. doi: 10.3390/ijms24119156.
6
Novel biomarkers for diabetic kidney disease.糖尿病肾病的新型生物标志物
Kidney Res Clin Pract. 2022 Sep;41(Suppl 2):S46-S62. doi: 10.23876/j.krcp.22.084. Epub 2022 Sep 30.
7
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.糖尿病肾病的病理生理机制及潜在生物标志物。
Diabetes Metab J. 2022 Mar;46(2):181-197. doi: 10.4093/dmj.2021.0329. Epub 2022 Mar 24.
8
Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.脂质组学揭示了糖尿病肾病患者血清中特定脂质的变化。
Front Endocrinol (Lausanne). 2021 Dec 9;12:781417. doi: 10.3389/fendo.2021.781417. eCollection 2021.
9
The effects of alprostadil combined with α-lipoic acid in the treatment of senile diabetic nephropathy.前列地尔联合α-硫辛酸治疗老年糖尿病肾病的疗效
Am J Transl Res. 2021 Sep 15;13(9):10823-10829. eCollection 2021.
10
A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease.一种用于慢性肾脏病间质纤维化和肾小管萎缩无创评估的新型尿液蛋白质组学分类器
Proteomes. 2021 Jul 13;9(3):32. doi: 10.3390/proteomes9030032.